Hoda Gabriel – President
Hoda Gabriel is a clinical research and development professional with 28 years of experience directing, designing, planning, and successfully executing early and late phase clinical drug programs within the pharmaceutical industry. As well as being the President of Oculus Research, Ms. Gabriel is currently the Sr. Director of Clinical Development at T3D Therapeutics. Prior to her current positions, she held director‐level positions with GlaxoSmithKline and Talecris (now Grifols), where she led several international programs and teams to successful NDA/MAA submissions. Additionally, she founded two independent clinical research companies. Ms. Gabriel has experience in the development of multiple therapeutic areas including CNS, Urology, Metabolic, Cardiovascular, Pain, Dermatology and Peripheral Arterial Disease.
Carol Aune, OD – Investigator and Director of Research
Carol Aune, OD is a graduate of the University of North Carolina at Chapel Hill and University of Houston College of Optometry. She is a practicing optometrist as well as a principal investigator for Oculus Research. She has years of experience diagnosing and treating a wide variety of eye disease as well fitting specialty contact lenses. She has been fully trained in clinical research including current GCP training. As the Principal Investigator and Research Director for Oculus Research she implements clinical trial protocols, clinical diagnoses and supervises patient care. She performs all clinical investigator responsibilities and supervision of study staff and site personnel.